Globus Medical Inc financial data

Symbol
GMED on NYSE
Industry
Surgical & Medical Instruments & Apparatus
Location
2560 General Armistead Avenue, Audubon, PA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 277 % -51.4%
Quick Ratio 113 % -44.7%
Debt-to-equity 26 % +38.5%
Return On Equity 2.29 % -64%
Return On Assets 1.82 % -66.1%
Operating Margin 4.67 % -67.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 136M shares -1.18%
Entity Public Float 4.6B USD +6.98%
Weighted Average Number of Shares Outstanding, Basic 136M shares +19.4%
Weighted Average Number of Shares Outstanding, Diluted 138M shares +19.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.48B USD +102%
Research and Development Expense 183M USD +100%
Operating Income (Loss) 116M USD -34.6%
Nonoperating Income (Expense) 8.93M USD +319%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 121M USD -40.2%
Income Tax Expense (Benefit) 29.5M USD -33.8%
Net Income (Loss) Attributable to Parent 91.5M USD -42%
Earnings Per Share, Basic 0.58 USD/shares -63.1%
Earnings Per Share, Diluted 0.57 USD/shares -63%

Balance Sheet

Label TTM Value / Value Unit Change %
Marketable Securities, Current 71.9M USD -62%
Accounts Receivable, after Allowance for Credit Loss, Current 588M USD +19%
Inventory, Net 718M USD -20.7%
Assets, Current 2.06B USD +7.26%
Deferred Income Tax Assets, Net 45.5M USD +522%
Property, Plant and Equipment, Net 568M USD -6.44%
Operating Lease, Right-of-Use Asset 52.8M USD -44.3%
Intangible Assets, Net (Excluding Goodwill) 843M USD -33.2%
Goodwill 1.43B USD +27.6%
Other Assets, Noncurrent 76.6M USD +10.3%
Assets 5.09B USD -5.04%
Accounts Payable, Current 57.5M USD -33.8%
Employee-related Liabilities, Current 138M USD +1.33%
Accrued Liabilities, Current 255M USD +15.2%
Liabilities, Current 818M USD +90.8%
Deferred Income Tax Liabilities, Net 7.48M USD -94.3%
Operating Lease, Liability, Noncurrent 86.4M USD -13.6%
Other Liabilities, Noncurrent 23M USD +2.6%
Liabilities 1.02B USD -13%
Accumulated Other Comprehensive Income (Loss), Net of Tax -6.96M USD +62.8%
Retained Earnings (Accumulated Deficit) 1.13B USD -16.4%
Stockholders' Equity Attributable to Parent 4.07B USD -2.82%
Liabilities and Equity 5.09B USD -5.04%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 52.4M USD -1.74%
Net Cash Provided by (Used in) Financing Activities -116M USD -4036%
Net Cash Provided by (Used in) Investing Activities -46.6M USD -524%
Common Stock, Shares Authorized 775M shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -113M USD -268%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 623M USD +123%
Deferred Tax Assets, Valuation Allowance 191M USD +3376%
Deferred Tax Assets, Gross 399M USD +314%
Operating Lease, Liability 97.4M USD -14%
Depreciation 139M USD +121%
Payments to Acquire Property, Plant, and Equipment 28.6M USD +78.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 103M USD -39.7%
Lessee, Operating Lease, Liability, to be Paid 143M USD -3.91%
Property, Plant and Equipment, Gross 1.07B USD +7.95%
Operating Lease, Liability, Current 11M USD -17.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 14.7M USD -0.33%
Lessee, Operating Lease, Liability, to be Paid, Year One 16.6M USD -8.15%
Operating Lease, Weighted Average Discount Rate, Percent 0.01 pure -96.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 45.3M USD +28.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 13.4M USD +0.25%
Unrecognized Tax Benefits 33.8M USD +3324%
Lessee, Operating Lease, Liability, to be Paid, Year Four 11.5M USD -6.54%
Operating Lease, Payments 4.76M USD +611%
Additional Paid in Capital 2.95B USD +3.21%
Amortization of Intangible Assets 118M USD +329%
Depreciation, Depletion and Amortization 55.3M USD +205%
Deferred Tax Assets, Net of Valuation Allowance 208M USD +129%
Share-based Payment Arrangement, Expense 53.9M USD +49.9%